Embecta Corp. will discuss its Q2 2026 results and operations in a conference call on May 5, 2026.
Quiver AI Summary
Embecta Corp. will hold a conference call on May 5, 2026, at 8:00 a.m. ET to discuss its fiscal second quarter 2026 financial results and provide an operational update. Participants can access the live webcast through the company's investor relations website or via teleconference. A replay will be available later the same day. Embecta, which has a 100-year history in insulin delivery, is expanding its focus to become a broader medical supplies company, emphasizing innovative solutions and partnerships. For more company information, visit embecta.com or follow their social media channels.
Potential Positives
- Embecta Corp. is transitioning from a specialized insulin delivery company to a broad-based medical supplies company, indicating growth and diversification.
- The scheduled conference call for fiscal second quarter 2026 financial results provides an opportunity for transparency and engagement with investors.
- The availability of a webcast replay for a year enhances accessibility for investors to review the company's performance and updates.
Potential Negatives
- None
FAQ
When is the conference call for embecta's fiscal second quarter 2026 results?
The conference call is scheduled for 8:00 a.m. ET on Tuesday, May 5, 2026.
How can I participate in the embecta conference call?
You can participate via the live webcast or teleconference, accessible through the links provided in the announcement.
Where can I find the webcast replay of the conference call?
The webcast replay will be available starting at 11:00 a.m. ET on May 5, 2026, on the embecta investor relations website.
What is the purpose of the conference call?
The call will discuss fiscal second quarter 2026 financial results, provide an operational update, and include a Q&A session.
Who to contact for media inquiries about embecta?
For media inquiries, contact Christian Glazar, Sr. Director of Corporate Communications, at 908-821-6922.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EMBC Revenue
$EMBC had revenues of $261.2M in Q1 2026.
You can track EMBC financials on Quiver Quantitative's EMBC stock page.
$EMBC Hedge Fund Activity
We have seen 132 institutional investors add shares of $EMBC stock to their portfolio, and 142 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 846,891 shares (-15.5%) from their portfolio in Q4 2025, for an estimated $10,061,065
- SG AMERICAS SECURITIES, LLC added 603,106 shares (+138.4%) to their portfolio in Q1 2026, for an estimated $5,331,457
- JEFFERIES FINANCIAL GROUP INC. added 470,096 shares (+24.9%) to their portfolio in Q4 2025, for an estimated $5,584,740
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 444,733 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $5,283,428
- UBS GROUP AG added 421,254 shares (+200.8%) to their portfolio in Q4 2025, for an estimated $5,004,497
- WELLINGTON MANAGEMENT GROUP LLP added 372,167 shares (+168.2%) to their portfolio in Q4 2025, for an estimated $4,421,343
- LSV ASSET MANAGEMENT added 265,482 shares (+92.5%) to their portfolio in Q4 2025, for an estimated $3,153,926
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EMBC Price Targets
Multiple analysts have issued price targets for $EMBC recently. We have seen 2 analysts offer price targets for $EMBC in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Anthony Petrone from Mizuho set a target price of $12.0 on 04/13/2026
- Marie Thibault from BTIG set a target price of $25.0 on 02/06/2026
Full Release
PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, May 5, 2026.
Those who would like to participate may access the live webcast here , or access the teleconference here . The live webcast can also be accessed via the company’s website at investors.embecta.com .
A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn , Facebook , and Instagram .
|
Contacts:
|
|
|
Media
Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations |
Investors
Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
